FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2053213629> ?p ?o ?g. }

• W2053213629 endingPage "299" @default.
• W2053213629 startingPage "290" @default.
• W2053213629 abstract "Survival rates for childhood acute lymphoblastic leukemia (ALL) have significantly improved and late effects of therapy have been important in the follow-up of survivors. The objective of this study is to identify the endocrinological and cardiological late effects of ALL patients treated in our pediatric hematology unit.Patients treated for ALL with BFM protocols after at least 5 years of diagnosis and not relapsed were included in the study. Endocrinological late effects (growth failure, obesity, insulin resistance, dyslipidemia, thyroid gland disorders, osteopenia/osteoporosis, and pubertal disorders) and cardiological late effects were evaluated. The study group was evaluated with anthropometric measurements, body mass index, and laboratory testing of fasting glucose, insulin, serum lipids, thyroid functions, and bone mineral densities. Echocardiography and pulsed wave Doppler imaging were performed for analysis of cardiac functions.Of the 38 ALL survivors, at least 1 adverse event occurred in 23 (60%), with 8 of them (21%) having multiple problems. Six (16%) of the survivors were obese and 8 (21%) of them were overweight. Subjects who were overweight or obese at the time of diagnosis were more likely to be overweight or obese at last follow-up. Obesity was more frequently determined in patients who were younger than 6 years of age at the time of diagnosis. Insulin resistance was observed in 8 (21%) subjects. Insulin resistance was more frequently seen in subjects who had family history of type 2 diabetes mellitus. Hyperlipidemia was detected in 8 (21%) patients. Hypothyroidism or premature thelarche were detected in 2 children. Two survivors had osteopenia. Cardiovascular abnormalities occurred in one of the subjects with hypertension and cardiac diastolic dysfunction.We point out the necessity of follow-up of these patients for endocrinological and cardiological late effects, since at least one adverse event occurred in most of our cases.None declared.Amaç: Akut lenfoblastik lösemili (ALL) çocuklarda sağkalım oranı belirgin düzelmiş ve izlemlerde geç yan etkiler açısından değerlendirilmeleri önemli hale gelmiştir. Bu çalışmanın amacı çocuk hematoloji kliniğimizde tedavisi tamamlanan akut lösemi olgularında uzun dönemde gelişebilecek endokrinolojik ve kardiyolojik geç etkilerin belirlenmesidir. Gereç ve Yöntemler: Lösemi tanısı aldığı tarihten itibaren en az beş yıl geçmiş, relaps gelişmemiş ve BFM protokolleri ile tedavi edilmiş hastalar endokrinolojik geç etkiler (boy kısalığı, obezite, insülin direnci, dislipidemi, tiroid hastalığı, osteopeni/osteoporoz, puberte sorunları) ve kardiyolojik geç etkiler açısından değerlendirildi. Çalışma grubunda antropometrik ölçümler, vücut kitle indeksi, açlık kan şekeri, insülin, serum lipid ve tiroid fonksiyon testleri ve kemik mineral dansiteleri araştırıldı. Kardiyak fonksiyonların analizinde ekokardiyografi ve pulsed Doppler görüntüleme kullanıldı.Bulgular: 38 olgudan 23’ünde (%60) en az bir, 8 olguda (%21) ise birden fazla geç etki olduğu görüldü. Altı olgunun (%16) fazla kilolu, 8’inin (%21) obez olduğu belirlendi. Tanı anında fazla kilolu ya da obez olanlarda ve tedavi bitiminde fazla kilolu ya da obez olanlarda son değerlendirmede obezite daha yüksek orandaydı. Tanı anında altı yaşın altında olanlarda obezite daha fazlaydı. Sekiz olguda (%21) insülin direnci vardı. Obez ya da fazla kilolu olanlarda ve ailede tip 2 DM öyküsü bulunanlarda insülin direnci daha yüksek oranda bulundu. Sekiz olguda (%21) hiperlipidemi saptandı. Hipotiroidi veya prematür telarş birer olguda, osteopeni 2 olguda görüldü. Kardiyolojik geç etki olarak bir olguda hipertansiyon ve hafif diastolik disfonksiyon olduğu belirlendi. Sonuç: Olguların çoğunda en az bir geç yan etki gözlendiğinden, bu çocukların endokrinolojik ve kardiyolojik geç etkiler açısından takip edilmelerinin gerekli olduğu ortaya çıkmaktadır ." @default.
• W2053213629 created "2016-06-24" @default.
• W2053213629 creator A5006472864 @default.
• W2053213629 creator A5008203584 @default.
• W2053213629 creator A5024004087 @default.
• W2053213629 creator A5050247791 @default.
• W2053213629 creator A5069337753 @default.
• W2053213629 creator A5076905574 @default.
• W2053213629 creator A5091662239 @default.
• W2053213629 date "2013-09-05" @default.
• W2053213629 modified "2023-09-27" @default.
• W2053213629 title "Endocrinological and Cardiological Late Effects Among Survivors of Childhood Acute Lymphoblastic Leukemia" @default.
• W2053213629 cites W145616348 @default.
• W2053213629 cites W1916063969 @default.
• W2053213629 cites W1968028835 @default.
• W2053213629 cites W1973592158 @default.
• W2053213629 cites W1977289240 @default.
• W2053213629 cites W1988829185 @default.
• W2053213629 cites W1989006808 @default.
• W2053213629 cites W1989831107 @default.
• W2053213629 cites W1993136022 @default.
• W2053213629 cites W1993593737 @default.
• W2053213629 cites W2011811997 @default.
• W2053213629 cites W2013012230 @default.
• W2053213629 cites W2015088283 @default.
• W2053213629 cites W2015758016 @default.
• W2053213629 cites W2018294737 @default.
• W2053213629 cites W2018677261 @default.
• W2053213629 cites W2033817226 @default.
• W2053213629 cites W2050627594 @default.
• W2053213629 cites W2051712218 @default.
• W2053213629 cites W2052476103 @default.
• W2053213629 cites W2054503358 @default.
• W2053213629 cites W2054863001 @default.
• W2053213629 cites W2055731160 @default.
• W2053213629 cites W2058713492 @default.
• W2053213629 cites W2060410445 @default.
• W2053213629 cites W2063923885 @default.
• W2053213629 cites W2072339309 @default.
• W2053213629 cites W2073850554 @default.
• W2053213629 cites W2077060147 @default.
• W2053213629 cites W2077104688 @default.
• W2053213629 cites W2083063948 @default.
• W2053213629 cites W2085033694 @default.
• W2053213629 cites W2086210969 @default.
• W2053213629 cites W2086355951 @default.
• W2053213629 cites W2088425181 @default.
• W2053213629 cites W2088758051 @default.
• W2053213629 cites W2090642962 @default.
• W2053213629 cites W2091493597 @default.
• W2053213629 cites W2092868590 @default.
• W2053213629 cites W2093312406 @default.
• W2053213629 cites W2094678299 @default.
• W2053213629 cites W2101119007 @default.
• W2053213629 cites W2103240149 @default.
• W2053213629 cites W2116169991 @default.
• W2053213629 cites W2124761182 @default.
• W2053213629 cites W2125316218 @default.
• W2053213629 cites W2131024291 @default.
• W2053213629 cites W2133879328 @default.
• W2053213629 cites W2140409181 @default.
• W2053213629 cites W2150719401 @default.
• W2053213629 cites W2151294542 @default.
• W2053213629 cites W2153217410 @default.
• W2053213629 cites W2159435579 @default.
• W2053213629 cites W2159810092 @default.
• W2053213629 cites W2161082810 @default.
• W2053213629 cites W2164433906 @default.
• W2053213629 cites W2165609679 @default.
• W2053213629 cites W2168324893 @default.
• W2053213629 cites W2168346876 @default.
• W2053213629 cites W2168581409 @default.
• W2053213629 cites W2231156824 @default.
• W2053213629 cites W2288605373 @default.
• W2053213629 cites W2335862295 @default.
• W2053213629 cites W2415372596 @default.
• W2053213629 cites W3159595310 @default.
• W2053213629 doi "https://doi.org/10.4274/tjh.2012.0094" @default.
• W2053213629 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3878537" @default.
• W2053213629 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24385809" @default.
• W2053213629 hasPublicationYear "2013" @default.
• W2053213629 type Work @default.
• W2053213629 sameAs 2053213629 @default.
• W2053213629 citedByCount "6" @default.
• W2053213629 countsByYear W20532136292015 @default.
• W2053213629 countsByYear W20532136292016 @default.
• W2053213629 countsByYear W20532136292017 @default.
• W2053213629 countsByYear W20532136292021 @default.
• W2053213629 countsByYear W20532136292022 @default.
• W2053213629 crossrefType "journal-article" @default.
• W2053213629 hasAuthorship W2053213629A5006472864 @default.
• W2053213629 hasAuthorship W2053213629A5008203584 @default.
• W2053213629 hasAuthorship W2053213629A5024004087 @default.
• W2053213629 hasAuthorship W2053213629A5050247791 @default.
• W2053213629 hasAuthorship W2053213629A5069337753 @default.
• W2053213629 hasAuthorship W2053213629A5076905574 @default.
• W2053213629 hasAuthorship W2053213629A5091662239 @default.
• W2053213629 hasBestOaLocation W20532136291 @default.

• next